Jean Perriot
Jean Perriot
Médecin Pneumologue-Addictologue, Conseil général du Puy-de Dôme
Verified email at - Homepage
Cited by
Cited by
Proportion of the GSTM 10/0 genotype in some slavic populations and its correlation with cystic fibrosis and some multifactorial diseases
VS Baranov, T Ivaschenko, B Bakay, M Aseev, R Belotserkovskaya, ...
Human genetics 97, 516-520, 1996
Peculiarities of GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis.
MP Baranova H, Perriot J, Albuisson E, Ivaschenko T, Baranov VS, Hemery B ...
Hum Genet. 99 (6), 822-6, 1997
Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial
P Mercié, J Arsandaux, C Katlama, S Ferret, A Beuscart, C Spadone, ...
The lancet HIV 5 (3), e126-e135, 2018
Tabacologie et sevrage tabagique
J Perriot, PM Llorca
John Libbey Eurotext, 2003
Environmental causes of asthma
DW Cockcroft
Seminars in respiratory and critical care medicine 39 (01), 012-018, 2018
La conduite de l’aide au sevrage tabagique
J Perriot
Revue des maladies respiratoires 23 (1), 3S85-3S105, 2006
Hypersexuality and pathological gambling in Parkinson's disease: A cross‐sectional case–control study
I de Chazeron, PM Llorca, I Chéreau‐Boudet, O Blanc, J Perriot, ...
Movement disorders 26 (11), 2127-2130, 2011
Les effets indésirables des antituberculeux; prise en charge
J Perriot, É Chambonnet, A Eschalier
Revue des maladies respiratoires 28 (4), 542-555, 2011
Influence de l’anxiété et de la dépression sur les exacerbations au cours de la BPCO
M Underner, A Cuvelier, G Peiffer, J Perriot, N Jaafari
Revue des maladies respiratoires 35 (6), 604-625, 2018
Cannabis smoking and lung cancer
M Underner, T Urban, J Perriot, I De Chazeron, JC Meurice
Revue des maladies respiratoires 31 (6), 488-498, 2014
Success rates in smoking cessation: Psychological preparation plays a critical role and interacts with other factors such as psychoactive substances
B Joly, J Perriot, P D’athis, E Chazard, G Brousse, C Quantin
PLoS One 12 (10), e0184800, 2017
Smoking cessation in smokers with chronic obstructive pulmonary disease
M Underner, J Perriot, G Peiffer
Revue des maladies respiratoires 31 (10), 937-960, 2014
Executive functions in tobacco dependence: importance of inhibitory capacities
V Flaudias, MC Picot, J Lopez-Castroman, PM Llorca, A Schmitt, J Perriot, ...
PLoS one 11 (3), e0150940, 2016
Le sevrage tabagique des «fumeurs difficiles»
J Perriot, M Underner, G Peiffer, J Le Houezec, L Samalin, A Schmitt, ...
Revue des maladies respiratoires 29 (4), 448-461, 2012
Smoking and tuberculosis
M Underner, J Perriot
Presse Medicale (Paris, France: 1983) 41 (12 Pt 1), 1171-1180, 2012
Adjustment of nicotine replacement therapies according to saliva cotinine concentration: the ADONIS* trial—a randomized study in smokers with medical comorbidities
I Berlin, N Jacob, M Coudert, J Perriot, L Schultz, N Rodon
Addiction 106 (4), 833-843, 2011
Tuberculosis and tobacco smoking
J Perriot, M Underner, G Peiffer
Journal of Tuberculosis 1 (1004), 1-4, 2018
Practical guidelines on e-cigarettes for practitioners and others health professionals. A French 2016 expert's statement
B Dautzenberg, M Adler, D Garelik, JF Loubrieu, G Mathern, G Peiffer, ...
Revue des Maladies Respiratoires, 2017
Les tests d’évaluation de la dépendance tabagique
M Underner, J Le Houezec, J Perriot, G Peiffer
Revue des maladies respiratoires 29 (4), 462-474, 2012
Tabac et tuberculose
M Underner, J Perriot
La Presse Médicale 41 (12), 1171-1180, 2012
The system can't perform the operation now. Try again later.
Articles 1–20